Home Depot and Chipotle Top 52-Week Stock Price Highs Thursday
Even though Thursday trading was quite flat at the close, these five stocks reached 52-week highs during the trading day:
Chipotle Mexican Grille (NYSE:CMG): The shares closed up 0.50 percent to $350.48. The stock’s 52-week trading range is $213.06 to $351.98.
On Wednesday, Goldman (NYSE:GS) upgraded Chipotle to Conviction Buy from Buy and added it to the Conviction Buy List for its strong earnings per share growth and lower food costs. The price target has been raised to $410 from $390.
Home Depot (NYSE:HD): The shares closed up 0.82 percent to $43.09. The stock’s 52-week trading range is $28.13 to $43.20.
In November, Home Depot raised its fiscal-year outlook after improving its distribution and boost customer service to take market share from its rival, Lowe’s Cos Inc. (NYSE:LOW). The company’s prosperity may also come from being in the right place at the right time and moving forward with technological advances and strategic plans, according to Seeking Alpha.
Celgene Corp. (NASDAQ:CELG): The shares closed up 0.87 percent to $68.51. The stock’s 52-week trading range is $48.92 to $69.26. In after-hours trading, Celgene dropped 1.8 percent after it announced the discontinuance of its Phase III trials for Revlimid, which helps treat prostate cancer.
Continental Resource (NYSE:CLR): The shares closed up 3.51 percent to $75.80. The stock’s 52-week trading range is $42.43 to $76.48. Continental said it will hit the upper end of its FY11 guidance with third quarter production estimated to be 70,000 barrels of oil equivalent per day.
The strong oil production in the latest quarter follows a weak second quarter after North Dakota flooding slowed operations.
Humana Inc. (NYSE:HUM): The shares closed up 1.95 percent to $91.68. The stock’s 52-week trading range is $54.96 to $91.76. According to Investment U, Humana is one the best 2012 defensive stocks, noting that the new healthcare rules will have a minimal impact and the firm has substantial growth potential.
Analysts have estimated the stock as a Buy (68 percent) with the balance viewing it as a Hold.
To contact the reporter on this story: Debbie Baratz at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com